Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells

Study to Evaluate Molecular Mechanics behind Synergistic Chemo-Preventive Effects of Curcumin and Resveratrol during Lung Carcinogenesis

(2014) Anshoo Malhotra et al.   PLoS One

TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer

(2014) W Xu et al.   Cell Death & Disease

Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines

(2013) Fatemehsadat Amiri et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest

(2012) Fabiana Casanova et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Chemosensitization of tumors by resveratrol

(2011) Subash C. Gupta et al.   Annals of the New York Academy of Sciences

BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin

(2010) Hyun Jeong Shim et al.   CANCER SCIENCE

Cancer Prevention With Natural Compounds

(2010) Norleena P. Gullett et al.   SEMINARS IN ONCOLOGY

Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms

(2009) Mohammad Athar et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro

(2008) M TOULANY et al.   DNA REPAIR